Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disease as a result of a selective degeneration of dopamine neurons in the substantia nigra. The selective loss of dopamine neurons in Parkinson’s disease is thought to involve altered expression or function of the plasma membrane and vesicular transporters for dopamine (1). The dopamine transporter (DAT) is exclusively found in dopaminergic neurons (2) and renders the dopamine neuron susceptible to neurotoxins, such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that can be transported by DAT into the neuron (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Miller, G. W., Gainetdinov, R. R., Levey, A. I., et al.(1999) Dopamine transporters and neuronal injury. Trends Pharmacol. Sci. 20, 424–429.
Giros, B., Jaber, M., Jones, S. R., et al. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606–612.
Noraberg, J., Kristensen, B. W., and Zimmer, J. (1999) Markers for neuronal degeneration in organotypic slice cultures. Brain Res. Protocols 3, 278–290.
Goldsworthy, S. M., Stockton, P. S., Trempus, C. S., et al. (1999) Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue. Mol. Carcinog. 25, 86–91
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Rho, O., Miller, G.W. (2003). Laser Capture Microdissection to Examine Transporter Expression in Specific Cell Regions. In: Yan, Q. (eds) Membrane Transporters. Methods in Molecular Biology, vol 227. Humana Press. https://doi.org/10.1385/1-59259-387-9:85
Download citation
DOI: https://doi.org/10.1385/1-59259-387-9:85
Publisher Name: Humana Press
Print ISBN: 978-1-58829-104-2
Online ISBN: 978-1-59259-387-3
eBook Packages: Springer Protocols